AU2003226812A1 - Oxygen carrier, selected from haemoglobin, myoglobin and their derivatives, for treating organ dysfunction/tissue damage caused by an acute supply deficiency - Google Patents

Oxygen carrier, selected from haemoglobin, myoglobin and their derivatives, for treating organ dysfunction/tissue damage caused by an acute supply deficiency

Info

Publication number
AU2003226812A1
AU2003226812A1 AU2003226812A AU2003226812A AU2003226812A1 AU 2003226812 A1 AU2003226812 A1 AU 2003226812A1 AU 2003226812 A AU2003226812 A AU 2003226812A AU 2003226812 A AU2003226812 A AU 2003226812A AU 2003226812 A1 AU2003226812 A1 AU 2003226812A1
Authority
AU
Australia
Prior art keywords
haemoglobin
myoglobin
derivatives
damage caused
tissue damage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003226812A
Inventor
Wolfgang Barnikol
Harald Potzschke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SANGUIBIOTECH GmbH
Original Assignee
Sanguibiotech AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanguibiotech AG filed Critical Sanguibiotech AG
Publication of AU2003226812A1 publication Critical patent/AU2003226812A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/41—Porphyrin- or corrin-ring-containing peptides
    • A61K38/42—Haemoglobins; Myoglobins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2003226812A 2002-05-11 2003-04-15 Oxygen carrier, selected from haemoglobin, myoglobin and their derivatives, for treating organ dysfunction/tissue damage caused by an acute supply deficiency Abandoned AU2003226812A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10220992.8 2002-05-11
DE10220992A DE10220992A1 (en) 2002-05-11 2002-05-11 Use of one or more oxygen carriers selected from hemoglobin, myoglobin and derivatives thereof for the treatment of an organ dysfunction due to an acute lack of supply and for the treatment / prevention of tissue damage due to such a disorder
PCT/EP2003/003911 WO2003094953A1 (en) 2002-05-11 2003-04-15 Oxygen carrier, selected from haemoglobin, myoglobin and their derivatives, for treating organ dysfunction/tissue damage caused by an acute supply deficiency

Publications (1)

Publication Number Publication Date
AU2003226812A1 true AU2003226812A1 (en) 2003-11-11

Family

ID=29413741

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003226812A Abandoned AU2003226812A1 (en) 2002-05-11 2003-04-15 Oxygen carrier, selected from haemoglobin, myoglobin and their derivatives, for treating organ dysfunction/tissue damage caused by an acute supply deficiency

Country Status (3)

Country Link
AU (1) AU2003226812A1 (en)
DE (1) DE10220992A1 (en)
WO (1) WO2003094953A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10352692A1 (en) 2003-11-12 2005-06-23 Sanguibiotech Gmbh Use of hypo-oncotic solutions in the blood of addable, hyperpolymeric hemoglobins for the treatment of pulmonary edema
EP2968597B1 (en) 2013-03-15 2021-08-18 Schindler, William Polyalkylene oxide valerate hemoglobin conjugates
DE102013014651A1 (en) 2013-09-03 2015-03-05 Sanguibiotech Gmbh Preparations for improved tissue oxygenation by peritoneal ventilation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5334706A (en) * 1992-01-30 1994-08-02 Baxter International Administration of low dose hemoglobin to increase perfusion
WO1996032130A1 (en) * 1995-04-10 1996-10-17 Baxter International Inc. The use of cross-linked hemoglobin in treating subarachnoid hemorrhage
ES2200177T3 (en) * 1996-03-28 2004-03-01 Northfield Laboratories, Inc. PROCEDURE AND APPARATUS TO PREPARE A RED-BLOCK ACECULAR SUBSTITUTE.
ATE302019T1 (en) * 1997-02-28 2005-09-15 Univ California METHOD AND COMPOSITIONS FOR OPTIMIZING OXYGEN TRANSPORT IN CELL-FREE SYSTEMS
DE10031742A1 (en) * 2000-06-29 2002-01-17 Sanguibio Tech Ag Production of cross-linked hemoglobin useful as artificial oxygen carrier comprises cross-linkage of hemoglobin in presence of a chemically inert effector of the hemoglobin oxygen affinity
DE10031740A1 (en) * 2000-06-29 2002-02-14 Sanguibio Tech Ag Artificial oxygen carriers from cross-linked modified human or pig hemoglobin with improved properties, processes for their technically simple production from purified material in high yields, and their use
DE10031744A1 (en) * 2000-06-29 2002-01-17 Sanguibio Tech Ag Mammalian hemoglobins compatible with blood plasma, crosslinked and conjugated with polyalkylene oxides as artificial medical oxygen carriers, their production and their use

Also Published As

Publication number Publication date
WO2003094953A1 (en) 2003-11-20
DE10220992A1 (en) 2003-12-04

Similar Documents

Publication Publication Date Title
AU2003207511A1 (en) Apparatus for preserving tissue
WO2003101508A8 (en) Wound treatment apparatus
AU2002336030A1 (en) Methods for preventing, treating or delaying cardiac toxicity using neuregulin
AP2210A (en) 4-tetrazolyl-4phenylpiperidine derivatives for treating pain.
AU2003232882A1 (en) Prostacyclin derivatives for treating cancer
AU2003234088A1 (en) Organism tissue suturing apparatus
AU2003275126A1 (en) Hemiasterlin derivatives for treating resistant tumors
IL164249A0 (en) Acyl-3-carboxphenylurea derivatives, processes forpreparing them and their use
EP1484366A4 (en) Treated pigment, use thereof, and compound for treating pigment
IL166624A0 (en) Taxane derivatives
EP1535971A4 (en) Treated pigment, use thereof, and compound for pigment treatment
ZA200204397B (en) Nitrile derivatives as cathepsin K inhibitors.
HUE042899T2 (en) Methods for preserving organs and tissues
AU2003237159A1 (en) Treatment for phenylketonuria
AU2003203378A1 (en) Suture insrument for biological use
EG24782A (en) Application of loading ledges.
AU2003297318A1 (en) Methods and compositions for treating cancer using 15986, 2188, 20743, 9148, 9151, 9791, 44252, 14184, 42461, 8204, 7970, 25552, 21657, 26492, 2411, 15088, 1905, 28899, 63380, 33935, 10480, 12686, 25501, 17694, 15701, 53062, 49908, 21612, 38949, 6216, 46863, 9235, 2201, 6985, 9883, 12238, 18057, 21617, 39228, 49928, 54476.
AU2003217832A1 (en) Catheter for treating vulnerable plaque
AU3168700A (en) An apparatus for land, sea, and air defence
AU2001283322A1 (en) Organic nutrient for hair loss treatment
IL164248A0 (en) Acyl-3-carboxyphenylurea derivatives, processes for preparing them and their use
AU2003226812A1 (en) Oxygen carrier, selected from haemoglobin, myoglobin and their derivatives, for treating organ dysfunction/tissue damage caused by an acute supply deficiency
AU2003283030A1 (en) Emission treatment system
AU2003264742A1 (en) Suture apparatus
AU2003285266A1 (en) Textile treatment agent

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase
TH Corrigenda

Free format text: IN VOL 18, NO 2, PAGE(S) 579 UNDER THE HEADING APPLICATIONS OPI - NAME INDEX UNDER THE NAME SANGUIBIOTECH GMBH, APPLICATION NO. 2003226812, UNDER INID (43) CORRECT THE PUBLICATION DATE TO READ 24.11.2003